C
T of patients with established cirrhosis shows diffuse surface nodularity of the liver and also may show decreased liver volume with relative hypertrophy of the left and caudate lobes or signs of portal hypertension. When seen at imaging, diffuse hepatic surface nodularity or signs of portal hypertension (i.e., splenomegaly, ascites, or portosystemic varices) are usually due to cirrhosis, but other conditions can also cause these findings. Knowledge of radiologic mimics of cirrhosis is increasingly important because some have been described only recently and because an erroneous diagnosis of cirrhosis in some settings could adversely impact contemporary treatment options. For example, underlying cirrhosis lowers the transplantation status of patients with acute hepatic failure. This article aims to provide a practical and current review of the conditions other than cirrhosis that can result in diffuse hepatic surface nodularity or signs of portal hypertension.
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hepatic failure developing in the setting of cirrhosis. The distinction of acute from acute-onchronic hepatic failure may be clinically difficult and hepatic surface nodularity might be considered indicative of underlying cirrhosis, adversely impacting transplantation status. Recently, fulminant hepatic failure alone was shown to result in diffuse surface nodularity because of a combination of alternating foci of confluent regenerative nodules and necrosis rather than cirrhosis [8] (Figs. 4 and 5) .
Miliary Metastases
Diffuse surface nodularity due to miliary metastases is rare (Figs. 6 and 7) and is unlikely to mimic cirrhosis. In a large ultrasound study [4] of hepatic metastases (n = 225), surface irregularity was observed in 16 patients (7%); in only two patients, one with squamous cell carcinoma of the tonsil and one with ovarian carcinoma, was surface nodularity the only sign of metastatic disease [4] .
Sarcoidosis
Sarcoidosis of the liver is common pathologically but is rarely visible at imaging because the noncaseating granulomas are usually microscopic. Occasionally, hepatic sarcoidosis can be visible as diffuse granular heterogeneity with or without fine nodularity of the hepatic surface [5] (Figs. 8 and 9 ).
Noncirrhotic Causes of Portal Hypertension

General Comments
Noncirrhotic causes of portal hypertension (Appendix 2) include chronic BuddChiari syndrome, chronic portal vein thrombosis, sarcoidosis, schistosomiasis, nodular regenerative hyperplasia, congenital hepatic fibrosis, idiopathic portal hypertension, and early primary biliary cirrhosis [9] .
Nodular Regenerative Hyperplasia
Nodular regenerative hyperplasia is a rare but increasingly recognized condition characterized by widespread transformation of normal liver parenchyma into hyperplastic regenerative nodules that vary in size from microscopic to large and masslike [10] ; the absence of fibrosis distinguishes nodular regenerative hyperplasia from cirrhosis. From a radiologic perspective, there appear to be two forms of the condition: a diffuse form in which the nodules are small and a widespread and a focal form in which the nodules are few in number, are scattered throughout the liver, and measure up to a few centimeters.
The pathogenesis of diffuse nodular regenerative hyperplasia is unknown, but there are well-recognized associations (Appendix 3) with systemic cardiovascular, myeloproliferative, and autoimmune diseases, particularly systemic lupus erythematosus; the administration of certain drugs including chemotherapy; solid organ and bone marrow transplantation; and HIV infection [10] . Focal nodular regenerative hyperplasia has been primarily reported in long-standing Budd-Chiari syndrome, although similar masses have also been reported in autoimmune hepatitis [11, 12] . Diffuse nodular regenerative hyperplasia frequently results in noncirrhotic portal hypertension [10] , and affected patients may present with variceal bleeding or hypersplenism.
Imaging findings in patients with nodular hyperplasia can be subtle across all techniques, although parenchymal findings may be more obvious on ultrasound than on CT or MRI [13] . At ultrasound, widespread nodularity suggestive of cirrhosis or multiple masses may be seen ( Fig. 10 ). At CT, the nodules may be hypodense with little enhancement. At MRI, diffuse nodular regenerative hyperplasia is usually of similar signal intensity to the liver on T1, T2, and gadolinium-enhanced sequences. Surface nodularity and features of portal hypertension may be seen across all techniques (Fig.  11 ). In focal nodular regenerative hyperplasia, CT or MRI typically shows multiple hypervascular masses in a patient with long-standing Budd-Chiari syndrome or autoimmune hepatitis. These masses may suggest metastases or hepatocellular carcinoma, although stability on follow-up studies or biopsy should help in making the correct diagnosis.
Early Primary Biliary Cirrhosis
Investigators recently found that portal hypertension can develop early in primary biliary cirrhosis-even before the onset of cirrhosis [14] -possibly resulting from compression of the portal venous branches by granulomatous inflammation causing presinusoidal fibrosis and portal hypertension [14] . This condition has been described as the portal hypertensive variant of primary biliary cirrhosis and appears to carry a higher risk of hepatocellular carcinoma than the other variants of primary biliary cirrhosis.
Congenital Hepatic Fibrosis
Hepatic involvement in this multisystem autosomal recessive disorder consists of widespread periportal fibrosis leading to portal hypertension [15] . Portal vein thrombosis is common, and segmental biliary dilatation may also be observed (Fig. 12) .
Idiopathic Portal Hypertension
Idiopathic portal hypertension is characterized by long-standing presinusoidal portal hypertension of unknown cause in adults and may reflect damage to the intrahepatic small portal veins or portal tracts by an immunologic disturbance, thromboembolism, or an infection. Imaging findings (Fig. 13) include subcapsular parenchymal atrophy, portal and parenchymal fibrosis, and portal venous thrombosis. Interestingly, cirrhosis does not develop even in the advanced stages of the disease [16] .
Conclusion
Diffuse surface nodularity of the liver or signs of portal hypertension usually reflect underlying cirrhosis, but noncirrhotic causes of these imaging findings include pseudocirrhosis of treated breast cancer metastases to the liver, fulminant hepatic failure, miliary metastases, sarcoidosis, schistosomiasis, congenital hepatic fibrosis, idiopathic portal hypertension, early primary biliary cirrhosis, chronic Budd-Chiari syndrome, chronic portal vein thrombosis, and nodular regenerative hyperplasia.
Pseudocirrhosis of treated breast cancer metastases can be easily identified by reviewing the patient's medical history and prior imaging examinations. Pseudocirrhosis of fulminant hepatic failure should be considered in previously healthy patients with acute liver decompensation. Miliary metastases should be considered when fine hepatic surface nodularity is seen in a patient with a known primary malignancy and no signs of portal hypertension. A raised serum angiotensin-converting enzyme level or mediastinal adenopathy suggests sarcoidosis. Congenital hepatic fibrosis should be considered in children with findings of portal hypertension, particularly if there are cysts in the kidneys. A smooth liver of normal size with features of portal hypertension should raise suspicion for idiopathic portal hypertension, but biopsy may be required because this diagnosis is one of exclusion. Diffuse nodular regenerative hyperplasia should be considered when multiple small masses are seen in the liver of a patient with known risk factors, particularly if the clinical picture does not favor malignancy and if the lesions are more prominent at ultrasound than on other techniques. Focal nodular regenerative hyperplasia should be considered when multiple hypervascular hepatic masses are seen in a patient with long-standing BuddChiari syndrome or autoimmune hepatitis.
Radiologic Mimics of Cirrhosis
Although these distinguishing features may be helpful, histologic correlation will be required to diagnose some cases. Careful radiologic analysis and clinical correlation may be required to prevent an erroneous diagnosis that could potentially adversely impact management. 
APPENDIX 1: Noncirrhotic Causes of Diffuse Hepatic Contour Irregularity
Radiologic Mimics of Cirrhosis
This article is available for CME credit. See www.arrs.org for more information. , but liver appears normal in size and contour. Liver biopsy confirmed absence of cirrhosis; final diagnosis was idiopathic portal hypertension.
